Curcumin pretreatment mediates antidiabetogenesis via functional regulation of adrenergic receptor subtypes in the pancreas of multiple low-dose streptozotocin-induced diabetic rats

Nutrition Research

Volumn 35, Issue 9, 2015, Pages 823-833

  Naijil, George ^a   Anju, T R ^a   Jayanarayanan, S ^a   Paulose, C S ^a  

^a Department of Physics   (India)

Author keywords

Adrenergic receptor; Curcumin; Diabetes; Pancreas; Cell

Indexed keywords

ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CURCUMIN; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIC GMP; GLUCOSE TRANSPORTER 2; INOSITOL TRISPHOSPHATE; INSULIN RECEPTOR; PHOSPHOLIPASE C; ADRENERGIC RECEPTOR STIMULATING AGENT; GLUCOSE BLOOD LEVEL; INSULIN; PLANT EXTRACT; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; APOPTOSIS; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOWN REGULATION; GLUCOSE METABOLISM; INSULIN RELEASE; INTRACELLULAR SIGNALING; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; UPREGULATION; ANIMAL; CHEMISTRY; CURCUMA; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; METABOLISM; PANCREAS; PHYTOTHERAPY; PREDIABETIC STATE; SECRETION (PROCESS); SIGNAL TRANSDUCTION; WISTAR RAT;

ADRENERGIC AGENTS; ANIMALS; BLOOD GLUCOSE; CURCUMA; CURCUMIN; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION; HYPERGLYCEMIA; INSULIN; INSULIN-SECRETING CELLS; MALE; PANCREAS; PHYTOTHERAPY; PLANT EXTRACTS; PREDIABETIC STATE; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, ADRENERGIC, BETA; SIGNAL TRANSDUCTION; STREPTOZOCIN;

EID: 84940888959     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2015.06.011     Document Type: Article

References (62)

1. IDF diabetes atlas International Diabetes Federation 2013, (Brussels, Belgium). 6th ed.
2. Szczepura A. Nutrition in an ethnically diverse society: what are some of the key challenges?. Proc Nutr Soc 2011, 70:252-262.
3. Zhang D., Ma Q., Wang Z., Zhang M., Guo K., Wang F., et al. β2-adrenoceptor blockage induces G1/S phase arrest and apoptosis in pancreatic cancer cells via Ras/Akt/NFκB pathway. Mol Cancer 2011, 10:146-151.
4. Maheshwari R.K., Singh A.K., Gaddipati J., Srimal R.C. Multiple biological activities of curcumin: a short review. Life Sci 2006, 78:2081-2087.
5. Suryanarayana P., Saraswat M., Mrudula T., Krishna T.P., Krishnaswamy K., Reddy G.B. Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats. Invest Ophthalmol Vis Sci 2005, 46:2092-2099.
6. Meghana K., Sanjeev G., Ramesh B. Curcumin prevents streptozotocin-induced islet damage by scavenging free radicals: a prophylactic and protective role. Eur J Pharmacol 2007, 577:183-191.
7. Peeyush K.T., Gireesh G., Jobin M., Paulose C.S. Neuroprotective role of curcumin in the cerebellum of streptozotocin-induced diabetic rats. Life Sci 2009, 85:704-710.
8. Thorens B. Brain glucose sensing and neural regulation of insulin and glucagon secretion. Diabetes Obes Metab 2011, 13:82-88.
9. Ahrén B. Autonomic regulation of islet hormone secretion-implications for health and disease. Diabetologia 2000, 43:393-410.
10. Mitrani P., Srinivasan M., Dodds C., Patel M.S. Role of the autonomic nervous system in the development of hyperinsulinemia by high-carbohydrate formula feeding to neonatal rats. Am J Physiol Endocrinol Metab 2007, 292:E1069-E1078.
11. Balkan B., Li X. Portal GLP-1 administration in rats augments the insulin response to glucose via neuronal mechanisms. Am J Physiol Regul Integr Comp Physiol 2000, 279:R1449-R4154.
12. Preitner F., Ibberson M., Franklin I., Binnert C., Pende M., Gjinovci A., et al. Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors. J Clin Invest 2004, 113:635-645.
13. Kanitkar M., Gokhale K., Galande S., Bhonde R.R. Novel role of curcumin in the prevention of cytokine-induced islet death in vitro and diabetogenesis in vivo. Br J Pharmacol 2008, 155:702-713.
14. Grama C.N., Suryanarayana P., Patil M.A., Raghu G., Balakrishna N., Kumar M.N., et al. Efficacy of biodegradable curcumin nanoparticles in delaying cataract in diabetic rat model. PLoS One 2013, 8:e78217.
15. Sharma S., Chopra K., Kulkarni S.K. Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: participation of nitric oxide and TNF-alpha. Phytother Res 2007, 21:278-283.
16. Like A.A., Rossini A.A. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 1976, 193:415-417.
17. George N., Kumar T.P., Antony S., Jayanarayanan S., Paulose C.S. Effect of vitamin D3 in reducing metabolic and oxidative stress in the liver of streptozotocin-induced diabetic rats. Br J Nutr 2012, 108:1410-1418.
18. Howell S.L., Taylor K.W. Potassium ions and the secretion of insulin by islets of Langerhans incubated in vitro. Biochem J 1968, 108:17-24.
19. Pipeleers D.G., Veld P.A., Van de Winkel M., Maes E., Schuit F.C., Gepts W. A new in vitro model for the study of pancreatic A and B cells. Endocrinology 1985, 117:806-816.
20. U'Prichard D.C., Snyder S.H. Binding of 3H-catecholamines to alpha-noradrenergic receptor sites in calf brain. J Biol Chem 1977, 252:6450-6463.
21. Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 1993, 15:532-537.
22. Shilpa J., Naijil G., Nandhu M.S., Paulose C.S. Evaluation of GABA-chitosan nanoparticle induced cell signaling activation during liver regeneration after partial hepatectomy. J Nanosci Nanotechnol 2012, 12:6145-6155.
23. Chen Y.I., Ren J., Wang F.N., Xu H., Mandeville J.B., Kim Y., et al. Inhibition of stimulated dopamine release and hemodynamic response in the brain through electrical stimulation of rat forepaw. Neurosci Lett 2007, 431:231-235.
24. Sherin A., Peeyush K.T., Naijil G., Nandhu M.S., Jayanarayanan S., Jes P., et al. The effects of abnormalities of glucose homeostasis on the expression and binding of muscarinic receptors in cerebral cortex of rats. Eur J Pharmacol 2011, 651:128-136.
25. Garber A.J., Handelsman Y., Einhorn D., Bergman D.A., Bloomgarden Z.T., Fonseca V., et al. Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists. Endocr Pract 2008, 14:933-946.
26. Tabák A.G., Herder C., Rathmann W., Brunner E.J., Kivimäki M. Prediabetes: a high-risk state for diabetes development. Lancet 2012, 379:2279-2290.
27. Del Prato S. Role of glucotoxicity and lipotoxicity in the pathophysiology of type 2 diabetes mellitus and emerging treatment strategies. Diabet Med 2009, 26:1185-1192.
28. Mobbs C.V., Isoda F., Makimura H., Mastaitis J., Mizuno T., Shu I.W., et al. Impaired glucose signaling as a cause of obesity and the metabolic syndrome: the glucoadipostatic hypothesis. Physiol Behav 2005, 85:3-23.
29. Liu M., Hodish I., Haataja L., Lara-Lemus R., Rajpal G., Wright J., et al. Proinsulin misfolding and diabetes: mutant INS gene-induced diabetes of youth. Trends Endocrinol Metab 2010, 21:652-659.
30. Kumar P.T., George N., Antony S., Paulose C.S. Curcumin restores diabetes induced neurochemical changes in the brain stem of Wistar rats. Eur J Pharmacol 2013, 702:32331.
31. Jayanarayanan S., Smijin S., Peeyush K.T., Anju T.R., Paulose C.S. NMDA and AMPA receptor mediated excitotoxicity in cerebral cortex of streptozotocin induced diabetic rat: ameliorating effects of curcumin. Chem Biol Interact 2013, 201:39-48.
32. Docherty J.R. Subtypes of functional alpha1- and alpha2-adrenoceptors. Eur J Pharmacol 1998, 361:1-15.
33. Peterhoff M., Sieg A., Brede M., Chao C.M., Hein L., Ullrich S. Inhibition of insulin secretion via distinct signaling pathways in alpha2-adrenoceptor knockout mice. Eur J Endocrinol 2003, 149:343-350.
34. Seino S., Takahashi H., Fujimoto W., Shibasaki T. Roles of cAMP signalling in insulin granule exocytosis. Diabetes Obes Metab 2009, 11:180-188.
35. 2+ concentration. J Biol Chem 1989, 264:973-980.
36. Rajan A.S., Aguilar-Bryan L., Nelson D.A., Yaney G.C., Hsu W.H., Kunze D.L., et al. Ion channels and insulin secretion. Diabetes Care 1990, 13:340-363.
37. Savontaus E., Fagerholm V., Rahkonen O., Scheinin M. Reduced blood glucose levels, increased insulin levels and improved glucose tolerance in alpha2A-adrenoceptor knockout mice. Eur J Pharmacol 2008, 578:359-364.
38. Berlin I., Rosenzweig P., Chalon S., Fuseau E., Landault C., Cesselin F., et al. Reduction of hyperglycemia after oral glucose load by the new alpha 2-adrenergic receptor antagonist SL 84. 0418 in healthy subjects. Clin Pharmacol Ther 1994, 55:338-345.
39. Abdel-Zaher A.O., Ahmed I.T., El-Koussi A.D. The potential antidiabetic activity of some alpha-2 adrenoceptor antagonists. Pharmacol Res 2001, 44:397-409.
40. 2-Adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NFκB and AP-1. Cancer Biol Ther 2010, 10:19-29.
41. Herr I., Debatin K.M. Cellular stress response and apoptosis in cancer therapy. Blood 2001, 98:2603-2614.
42. McCubrey J.A., Steelman L.S., Chappell W.H., Abrams S.L., Wong E.W., Chang F., et al. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta 1773, 2007:1263-1284.
43. van der Weyden L., Adams D.J. The Ras-association domain family (RASSF) members and their role in human tumourigenesis. Biochim Biophys Acta 1776, 2007:58-85.
44. Karoor V., Malbon C.C. Insulin-like growth factor receptor-1 stimulates phosphorylation of the beta2-adrenergic receptor in vivo on sites distinct from those phosphorylated in response to insulin. J Biol Chem 1996, 271:29347-29352.
45. Dalle S., Quoyer J., Varin E., Costes S. Roles and regulation of the transcription factor CREB in pancreatic β-cells. Curr Mol Pharmacol 2011, 4:187-195.
46. Jhala U.S., Canettieri G., Screaton R.A., Kulkarni R.N., Krajewski S., Reed J., et al. cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. Genes Dev 2003, 17:1575-1580.
47. Jambal P., Masterson S., Nesterova A., Bouchard R., Bergman B., Hutton J.C., et al. Cytokine-mediated down-regulation of the transcription factor cAMP-response element-binding protein in pancreatic beta-cells. J Biol Chem 2003, 278:23055-23065.
48. Costes S., Broca C., Bertrand G., Lajoix A.D., Bataille D., Bockaert J., et al. ERK1/2 control phosphorylation and protein level of cAMP-responsive element-binding protein: a key role in glucose-mediated pancreatic beta-cell survival. Diabetes 2006, 55:2220-2230.
49. De Camilli P., Emr S.D., McPherson P.S., Novick P. Phosphoinositides as regulators in membrane traffic. Science 1996, 271:1533-1539.
50. Jackerott M., Baudry A., Lamothe B., Bucchini D., Jami J., Joshi R.L. Endocrine pancreas in insulin receptor-deficient mouse pups. Diabetes 2001, 50:S146-S149.
51. Kulkarni R.N., Brüning J.C., Winnay J.N., Postic C., Magnuson M.A., Kahn C.R. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 1999, 96:329-339.
52. Leibiger I.B., Leibiger B., Berggren P.O. Insulin signaling in the pancreatic beta-cell. Annu Rev Nutr 2008, 28:233-251.
53. Ferrer J., Benito C., Gomis R. Pancreatic islet GLUT2 glucose transporter mRNA and protein expression in humans with and without NIDDM. Diabetes 1995, 44:1369-1374.
54. Wang Z., Gleichmann H. GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice. Diabetes 1998, 47:50-56.
55. Guillam M.T., Hümmler E., Schaerer E., Yeh J.I., Birnbaum M.J., Beermann F., et al. Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2. Nat Genet 1997, 17:327-330.
56. Holz G.G. Epac: a new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell. Diabetes 2004, 53:5-13.
57. Pilz R.B., Broderick K.E. Role of cyclic GMP in gene regulation. Front Biosci 2005, 10:1239-1268.
58. McCarty M.F. cGMP may have trophic effects on beta cell function comparable to those of cAMP, implying a role for high-dose biotin in prevention/treatment of diabetes. Med Hypotheses 2006, 66:323-328.
59. 2+ concentration of rat pancreatic beta-cells. J Pharmacol Sci 2003, 91:41-46.
60. Somesh B.P., Verma M.K., Sadasivuni M.K., Mammen-Oommen A., Biswas S., Shilpa P.C., et al. Chronic glucolipotoxic conditions in pancreatic islets impair insulin secretion due to dysregulated calcium dynamics, glucose responsiveness and mitochondrial activity. BMC Cell Biol 2013, 14:31-38.
61. Dyachok O., Idevall-Hagren O., Sågetorp J., Tian G., Wuttke A., Arrieumerlou C., et al. Glucose-induced cyclic AMP oscillations regulate pulsatile insulin secretion. Cell Metab 2008, 8:26-37.
62. Ireson C.R., Jones D.J., Orr S., Coughtrie M.W., Boocock D.J., Williams M.L., et al. Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol Biomarkers Prev 2002, 11:105-111.